Administration of HMGB1-specific neutralizing antibodies beginning 24 hours after the onset of sepsis induced by CLP was shown to lead to a dose-dependent rescue of mice from lethal sepsis[4-6]. The gene discussed is HMGB1; the disease is Sepsis.